What does APOTHEEK DEMEYERE do?

APOTHEEK DEMEYERE is a pharmacy in Kruisem. Private Limited, started on 14 June 1982, 1 establishment.

What is the address of APOTHEEK DEMEYERE?

The registered office of APOTHEEK DEMEYERE is located at Strijpstraat 35, 9750 Kruisem.

Is APOTHEEK DEMEYERE still active?

Yes. According to the CBE (30 October 2026) APOTHEEK DEMEYERE is active, legal situation “Normale toestand”, started on 14 June 1982.

Is APOTHEEK DEMEYERE registered on Peppol?

Yes, APOTHEEK DEMEYERE is registered on the Peppol network with ID 0208:0422822208.

What is the enterprise number of APOTHEEK DEMEYERE?

The enterprise number of APOTHEEK DEMEYERE is BE0422822208.

When was APOTHEEK DEMEYERE founded?

APOTHEEK DEMEYERE was founded on 14 June 1982.

Who are the directors of APOTHEEK DEMEYERE?

According to the 2025 annual accounts, the directors of APOTHEEK DEMEYERE are: PHAROVENT.

Is APOTHEEK DEMEYERE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 June 1982; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK DEMEYERE make in 2025?

APOTHEEK DEMEYERE posted a profit after taxes of € 129,304 in financial year 2025.

What is the revenue of APOTHEEK DEMEYERE?

As a small company, APOTHEEK DEMEYERE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 225,907.

How much does an employee at APOTHEEK DEMEYERE earn?

The average wage cost per full-time employee at APOTHEEK DEMEYERE was € 56,500 in 2025: staff costs of € 79,049 for 1.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK DEMEYERE have?

According to the 2025 annual accounts, APOTHEEK DEMEYERE has 1.4 full-time equivalents (FTE).

APOTHEEK DEMEYERE (Private Limited) - Kruisem

Dossier APOTHEEK DEMEYERE, printed on 30 October 2026 from databakkes.be/en/0422822208/apotheek-demeyere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 1.7 to 1.4.

Financials

Financial year 2025

APOTHEEK DEMEYERE from Kruisem, company number BE0422822208, closed financial year 2025 with a result of € 129,304 after tax. For that financial year APOTHEEK DEMEYERE recorded a gross margin of € 225,907 and equity of € 998,062. Compared with financial year 2024, the result moved from € 57,553 to € 129,304. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 30, 2026.

What it is worth Growing

€ 998,062

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 129,304

▲ 125% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 69,237

▼ 51% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 129,000 paid out

100 % of the profit went to the shareholders, mostly to PHAROVENT (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.4

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 79,049

▼ 7% vs 2024

€ 56,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,670

▼ 36% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 146,667

▼ 13% vs 2024

€ 22,000 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 67,722

▼ 54% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 12,439

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 180,936 Gross margin 2022: € 180,936 First fiscal year in the series	€ 146,196 Gross margin 2023: € 146,196 ▼ 19% vs 2022 (€ 180,936) Unfavourable step	€ 162,454 Gross margin 2024: € 162,454 ▲ 11% vs 2023 (€ 146,196) Favourable step	€ 225,907 Gross margin 2025: € 225,907 ▲ 39% vs 2024 (€ 162,454) Favourable step	▲ 39%
Profit after taxes	€ 135,952 Profit after taxes 2022: € 135,952 First fiscal year in the series	€ 52,418 Profit after taxes 2023: € 52,418 ▼ 61% vs 2022 (€ 135,952) Unfavourable step	€ 57,553 Profit after taxes 2024: € 57,553 ▲ 10% vs 2023 (€ 52,418) Favourable step	€ 129,304 Profit after taxes 2025: € 129,304 ▲ 125% vs 2024 (€ 57,553) Favourable step	▲ 125%
Equity	€ 974,787 Equity 2022: € 974,787 First fiscal year in the series	€ 977,205 Equity 2023: € 977,205 Unchanged (€ 974,787) Favourable step	€ 997,758 Equity 2024: € 997,758 ▲ 2% vs 2023 (€ 977,205) Favourable step	€ 998,062 Equity 2025: € 998,062 Unchanged (€ 997,758) Favourable step
Total debts	€ 516,312 Total debts 2022: € 516,312 First fiscal year in the series	€ 481,674 Total debts 2023: € 481,674 ▼ 7% vs 2022 (€ 516,312) Favourable step	€ 366,238 Total debts 2024: € 366,238 ▼ 24% vs 2023 (€ 481,674) Favourable step	€ 381,400 Total debts 2025: € 381,400 ▲ 4% vs 2024 (€ 366,238) Unfavourable step	▲ 4%
Cash	€ 363,585 Cash 2022: € 363,585 First fiscal year in the series	€ 192,836 Cash 2023: € 192,836 ▼ 47% vs 2022 (€ 363,585) Unfavourable step	€ 141,456 Cash 2024: € 141,456 ▼ 27% vs 2023 (€ 192,836) Unfavourable step	€ 69,237 Cash 2025: € 69,237 ▼ 51% vs 2024 (€ 141,456) Unfavourable step	▼ 51%
Land & buildings	€ 46,213 Land & buildings 2022: € 46,213 First fiscal year in the series	€ 17,215 Land & buildings 2023: € 17,215 ▼ 63% vs 2022 (€ 46,213) Unchanged	€ 75,477 Land & buildings 2024: € 75,477 ▲ € 58,262 vs 2023 (€ 17,215) Unchanged	€ 71,179 Land & buildings 2025: € 71,179 ▼ 6% vs 2024 (€ 75,477) Unchanged	▼ 6%
Retained profit	€ 956,237 Retained profit 2022: € 956,237 First fiscal year in the series	€ 958,655 Retained profit 2023: € 958,655 Unchanged (€ 956,237) Favourable step	€ 979,208 Retained profit 2024: € 979,208 ▲ 2% vs 2023 (€ 958,655) Favourable step	€ 979,512 Retained profit 2025: € 979,512 Unchanged (€ 979,208) Favourable step
Dividend	€ 134,000 Dividend 2022: € 134,000 First fiscal year in the series	€ 50,000 Dividend 2023: € 50,000 ▼ 63% vs 2022 (€ 134,000) Unchanged	€ 37,000 Dividend 2024: € 37,000 ▼ 26% vs 2023 (€ 50,000) Unchanged	€ 129,000 Dividend 2025: € 129,000 ▲ 249% vs 2024 (€ 37,000) Unchanged	▲ 249%
Bank debt	€ 214,500 Bank debt 2022: € 214,500 First fiscal year in the series	€ 192,500 Bank debt 2023: € 192,500 ▼ 10% vs 2022 (€ 214,500) Favourable step	€ 168,667 Bank debt 2024: € 168,667 ▼ 12% vs 2023 (€ 192,500) Favourable step	€ 146,667 Bank debt 2025: € 146,667 ▼ 13% vs 2024 (€ 168,667) Favourable step	▼ 13%
Balance sheet total	€ 1,491,099 Balance sheet total 2022: € 1,491,099 First fiscal year in the series	€ 1,458,879 Balance sheet total 2023: € 1,458,879 ▼ 2% vs 2022 (€ 1,491,099) Unchanged	€ 1,363,996 Balance sheet total 2024: € 1,363,996 ▼ 7% vs 2023 (€ 1,458,879) Unchanged	€ 1,379,462 Balance sheet total 2025: € 1,379,462 ▲ 1% vs 2024 (€ 1,363,996) Unchanged	▲ 1%
Employees (FTE)	1.4 Employees (FTE) 2022: 1.4 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 ▲ 0.3 vs 2022 (1.4) Unchanged	1.5 Employees (FTE) 2024: 1.5 ▼ 0.2 vs 2023 (1.7) Unchanged	1.4 Employees (FTE) 2025: 1.4 ▼ 0.1 vs 2024 (1.5) Unchanged	▼ 0.1

Key figures of APOTHEEK DEMEYERE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to APOTHEEK DEMEYERE?

What happened at APOTHEEK DEMEYERE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 30, 2026 New annual accounts for financial year 2025: profit of € 129,304 (▲ 125% vs 2024). Source: NBB ↗
2014 PHAROVENT became a director. NBB
Jun 14, 1982 New establishment in Kruisem. KBO
Jun 14, 1982 Start of the company according to the CBE. KBO

In short

From € 135,952 profit in 2022 to € 129,304 profit in 2025.

Paid € 2,191 in corporate taxes since 2022.

Best year ever: 2022, with € 135,952 profit.

On average € 161,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PHAROVENT 99.9%

The stake of PHAROVENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK DEMEYERE

Behind APOTHEEK DEMEYERE is PHAROVENT. The shares are held by PHAROVENT (99.9%).

Directors

According to the 2025 annual accounts

PHAROVENT

Director · represented by Demeyere Tineke

since 2014

Shareholders

PHAROVENT

99.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Strijpstraat 35

9750 Kruisem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

PHAROVENT same network

€ 166,958 gross margin · 2025

'GROEP DEMEYERE'

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0422.822.208

VAT number

BE 0422.822.208

Registered office

Strijpstraat 35, 9750 Kruisem

Names & denominations

APOTHEEK DEMEYERE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 June 1982

Peppol

Active · Active since 27 Aug 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK DEMEYERE

Warning lights

Financials

What happened to APOTHEEK DEMEYERE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions